All of these cytokines, TNF‐α, IL‐10, and IFN‐γ, are targets for treating different pulmonary diseases [36, 37]; for example, administration of recombinant human IFN‐γ results in favorable respiratory outcomes in patients exposed to sulfur mustard [38, 39]. Here, IL10 is linked to lung disorder.